Clinical Trials
4 trialsNCT01227408 2017-05-02
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
University of Southern California
Phase 2 Withdrawn
NCT00265733 2016-12-06
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00270907 2013-02-13
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00148707 2007-12-21
Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed